Payers and gastroenterologists expressed shared excitement for the potential Janus kinase inhibitors have in treating inflammatory bowel disease, according to a survey by Decision Resources Group.
GI & Endoscopy
Colorectal cancer death rates in 50-year-old adults sharply increased, according to a new study in JAMA, CNN reports.
Theravance Biopharma revealed early data from its phase 1b clinical trial for its ulcerative colitis drug TD-1473.
Lexington (Ky.) Clinic Gastroenterology operates out of the Lexington Clinic Ambulatory Surgery Center.
Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 31 to Aug. 4.
Christopher Kulisek, MD, is a gastroenterologist and the founder of Knoxville, Tenn.-based West Knox Gastroenterology.
RD Biomed registered its reflux disease testing device Peptest with the FDA, Inside Media Limited reports.
The Independent Data Monitoring Committee completed a planned analysis of the first half of Celsion's phase III study of ThermoDox, its liver cancer drug.
The European Commission awarded Bayer marketing authorization for its second line liver cancer treatment Stivarga, Pipeline Review.com reports.
The single specialty gastroenterology and hepatology practice Gastro Group & EndoCenter has been serving Slidell and Covington, La. for more than 30 years.
